Most people walk into a physical expecting a “complete” set of labs. The problem is that complete means different things for different people.

I favor a comprehensive baseline that looks across cardiovascular, metabolic, thyroid, nutrient, hormonal, kidney, liver, blood, and inflammatory systems. The interpretation still has to begin with one question: What will this result change?

A useful physical combines that broad foundation with targeted testing based on age, symptoms, medications, personal history, and family history. It should be thorough without becoming a random hunt for abnormal numbers.

Start with the big picture

Ask your physician: What are the two or three biggest threats to my health over the next decade?

The answer should reflect more than your age. Blood pressure, tobacco exposure, weight, cholesterol, glucose, kidney function, sleep, activity, medications, pregnancy history, and family history all change risk.

Then ask: If I change one thing this year, what would give me the greatest return?

For one person, that may be treating blood pressure. For another, it may be stopping tobacco, improving sleep apnea treatment, increasing strength training, reducing alcohol, or taking a medication consistently. The highest-value intervention is often not the newest test.

Build the family-risk map first

Before ordering advanced tests, document which first- and second-degree relatives developed heart attack, stroke, diabetes, kidney disease, dementia, or cancer, and at what age. “Heart disease runs in the family” is less useful than “my father had a heart attack at 49.” Premature disease can change lipid testing, treatment thresholds, imaging decisions, and genetic counseling.

For cancer, note the organ involved, age at diagnosis, whether multiple relatives were affected on the same side of the family, and whether anyone had more than one primary cancer. Patterns involving early breast, ovarian, pancreatic, prostate, colorectal, or endometrial cancer may justify genetic counseling rather than simply adding more blood tests.

A strong baseline laboratory set

A broad baseline can be reasonable, particularly when someone has not been assessed in years. These categories capture much of what I find useful in comprehensive panels while keeping each test tied to a clinical decision.

Blood count

A complete blood count measures red cells, white cells, and platelets. It can identify anemia, abnormal cell counts, or clues to bleeding and chronic disease. An abnormal CBC is a starting point, not a diagnosis.

Kidney, liver, and electrolytes

A comprehensive metabolic panel includes glucose, creatinine with estimated GFR, sodium, potassium, bicarbonate, calcium, albumin, and liver-associated enzymes. It is especially useful in people with hypertension, diabetes, obesity, kidney or liver risk, alcohol exposure, or medications that affect these systems.

Add a urine albumin-to-creatinine ratio when diabetes, hypertension, or kidney risk is present. Estimated GFR measures filtration. Urine albumin detects kidney damage that may appear before filtration falls.

Metabolic health

Hemoglobin A1c and fasting glucose screen for diabetes and prediabetes. A fasting insulin level can sometimes reveal compensatory hyperinsulinemia earlier, but there is no universally accepted cutoff that independently dictates treatment. Waist circumference, blood pressure, triglycerides, HDL, glucose, and the trend over time often tell a more actionable story.

Lipid panel

A standard lipid panel remains foundational, but LDL cholesterol does not always reflect the number of plaque-forming particles.

Apolipoprotein B approximates the total number of atherogenic particles. It is particularly useful when LDL cholesterol and particle burden may be discordant, including diabetes, metabolic syndrome, elevated triglycerides, or known cardiovascular disease.

Lipoprotein(a) is largely inherited and is not included in a routine cholesterol panel. Current cardiovascular guidance supports measuring it at least once in adulthood. A high result should sharpen attention to every modifiable risk factor and may justify testing first-degree relatives.

High-sensitivity CRP can occasionally refine cardiovascular risk, but it is nonspecific. Infection, injury, and chronic inflammatory conditions can raise it. It should never be interpreted alone.

Thyroid and nutrients

TSH is the usual starting thyroid test. Free T4, T3, and thyroid antibodies are more useful when the TSH is abnormal or symptoms, pregnancy, medication exposure, goiter, or autoimmune history create a reason to look deeper.

A comprehensive nutrient assessment can include ferritin, iron, iron-binding capacity, iron saturation, vitamin D, magnesium, zinc, homocysteine, and methylmalonic acid as a functional marker of vitamin B12 status. Results should still be connected to diet, symptoms, medications, bone health, malabsorption, and a treatment plan.

The Omega-3 Index

The Omega-3 Index is different from asking how often someone eats fish or measuring a short-term plasma level. It measures EPA plus DHA in red blood-cell membranes as a percentage of total red-cell fatty acids, providing a longer-term picture of tissue exposure.

Lower values have been associated with greater cardiovascular and sudden cardiac-death risk. An index below 4% has traditionally been considered low, while 8% or higher has been proposed as a favorable range. The association is useful, but the test is not yet part of every major preventive-care guideline, and reaching a target with supplements has not been proven to eliminate cardiovascular risk.

I still find the measurement valuable because it answers a distinct question: are EPA and DHA actually being incorporated into the body over time? If it is measured, interpret it alongside triglycerides, ApoB, Lp(a), blood pressure, glucose, diet, medications, bleeding risk, and atrial-fibrillation history. Other fatty-acid measurements, including EPA, DHA, DPA, arachidonic acid, and omega-6 to omega-3 ratios, may provide additional dietary context, but the red-cell Omega-3 Index is the clearest longitudinal marker.

Female hormone health

When reproductive stage, menstrual changes, fertility, menopause symptoms, bone health, or treatment decisions make the information useful, the discussion can include estradiol, total and free testosterone, sex hormone-binding globulin, DHEA-S, LH, FSH, prolactin, and anti-Müllerian hormone. Progesterone requires attention to menstrual timing. A hormone result without age, symptoms, cycle timing, medication use, and clinical context is easy to misinterpret.

Male hormone and prostate health

A thoughtful male assessment can include morning total testosterone, calculated or measured free testosterone, sex hormone-binding globulin, estradiol, DHEA-S, LH, FSH, prolactin, and in selected cases dihydrotestosterone. Low testosterone should generally be confirmed on a separate morning measurement and interpreted alongside symptoms, sleep, weight, medications, fertility goals, and pituitary or testicular signals.

For men considering prostate screening, total PSA is the starting test. Free PSA and percent-free PSA can help refine the meaning of a borderline total PSA in selected situations. PSA is not a simple cancer yes-or-no test. Age, ancestry, prostate symptoms, medications, prior values, life expectancy, and family history of prostate, breast, ovarian, or pancreatic cancer should shape the decision.

Additional comprehensive markers

Other broad panels may include uric acid, leptin, GGT, homocysteine, morning cortisol, IGF-1, fibrinogen, a neutrophil-to-lymphocyte ratio calculated from the CBC, a complete urinalysis, lead, mercury, ANA, rheumatoid factor, amylase, and lipase. Fasting glucose and insulin can also be used to calculate HOMA-IR as a research-informed estimate of insulin resistance, although thresholds and clinical use are not fully standardized.

I support having access to this breadth, but these results do not all carry the same screening value. IGF-1 and DHT need a defined hormonal question. Fibrinogen and inflammatory ratios can be nonspecific. Exposure history should guide metals. Symptoms should guide pancreatic and autoimmune testing. A positive ANA in an otherwise healthy person may create confusion rather than clarity.

Infections

Most adults should have at least one hepatitis C and HIV screening test, with repeat testing based on exposure and risk. Hepatitis B screening and immunity assessment may also be appropriate depending on age, pregnancy, birthplace, vaccination, and risk.

Where coronary calcium fits

A coronary artery calcium scan is a low-dose, noncontrast CT that measures calcified plaque. It is not a blood test and it is not a universal screening study.

Current cardiovascular guidance supports selective CAC testing when a prevention decision remains uncertain, particularly for men age 40 and older and women age 45 and older with borderline or intermediate estimated risk. It can be especially helpful when cholesterol, blood pressure, family history, and patient preference point in different directions.

A score of zero can be reassuring in the right person, but it does not erase risk from diabetes, smoking, a strong history of premature coronary disease, or markedly elevated LDL or Lp(a). Any calcium is evidence of coronary atherosclerosis. The value of the scan is whether it changes the prevention plan.

Cancer risk deserves its own plan

Ask which proven screening tests you are due for based on age, anatomy, prior results, tobacco exposure, and family history. That may include colorectal, breast, cervical, lung, or prostate cancer screening.

Routine tumor markers such as CEA, CA-125, CA 19-9, or AFP are generally not effective screening tests in asymptomatic, average-risk adults. Multi-cancer blood tests are promising, but they should not replace established screening, and evidence that they reduce mortality is still developing.

The practical checklist

  1. What are my top cardiovascular, metabolic, kidney, and cancer risks?
  2. What conditions occurred early in my family, and does that change my plan?
  3. Do I need ApoB and a once-in-adulthood Lp(a)?
  4. Would a CAC score change a statin or prevention decision at my age?
  5. Which cancer screening am I due for, and do I meet criteria for genetic counseling?
  6. Which thyroid, nutrient, female or male hormone tests fit my symptoms and stage of life?
  7. Would an Omega-3 Index add useful information about my longer-term EPA and DHA status?
  8. Should prostate assessment include PSA, free PSA, or percent-free PSA?
  9. Why is each additional lab being ordered, and what result would change management?

Questions people often forget

Before you go

Bring an accurate medication and supplement list, several home blood-pressure readings if you have them, your vaccine record, and any new family diagnoses. Write down your top three questions before the visit.

A useful physical should end with a plan you understand: what is being measured, why it matters, what will be repeated, and which one or two actions offer the greatest return.

Comprehensive testing can be valuable. The goal is not to collect the most data. It is to connect the right data to better decisions.